Hepatitis B is another liver infection caused by a different virus. You can get it through contact with infected blood, like sharing needles, or through sexual contact. It can also be passed from an infected mother to her baby during birth. It can cause long-term liver damage if not treated.
Every report comes from a Lived member, sent anonymously.
Have you tried Tenofovir for Hepatitis B?
Hepatitis B is an infection of the liver caused by the hepatitis B virus. The virus inflames liver cells, and over many years that ongoing inflammation can scar the liver and raise the risk of liver cancer. The infection takes two forms. A new, or acute, infection may cause a few weeks of illness with tiredness, nausea, dark urine and yellowing of the skin and eyes, or it may cause no symptoms at all. Most adults clear the virus on their own. When the virus is still present after six months, the infection is called chronic, and it usually lasts for life. Age at infection matters a great deal: babies infected at birth and young children are much more likely than adults to develop chronic hepatitis B. Chronic hepatitis B often causes no symptoms for decades, which is why many people who have it do not know. It can be well managed, but because it is silent, finding it through a blood test is the step that makes care possible.
Hepatitis B spreads through contact with the blood, semen or other body fluids of someone who has the virus. The most common routes are from a mother to her baby at birth, through sex, and through sharing needles or other equipment for injecting drugs. It can also spread through needlestick injuries at work, tattooing or piercing with unsterile tools, and sharing razors, toothbrushes or nail clippers. It does not spread through hugging, coughing, sharing food or eating utensils, or casual contact. Risk is higher for people born in, or whose parents came from, regions where hepatitis B is common, including much of Asia, Africa and parts of the Middle East and Eastern Europe. Most people in the United States who live with chronic hepatitis B were born elsewhere, often infected at birth or in early childhood. Other risk factors include having a sex partner or household member with hepatitis B, multiple sex partners, being a man who has sex with men, HIV (human immunodeficiency virus) or hepatitis C, kidney dialysis, and time in jail or prison. None of these is a judgment about the person; many people acquired the virus as infants. Vaccination prevents hepatitis B, and someone who is already immune from vaccination or a past infection cannot catch it again.
Hepatitis B is diagnosed with blood tests. In the United States, the Centers for Disease Control and Prevention (CDC) recommends that every adult be tested at least once, even without symptoms, and that pregnant people be tested in every pregnancy. The recommended screen uses three markers, and together they answer different questions. Hepatitis B surface antigen (HBsAg) is a piece of the virus itself; a positive result means the infection is present now. Surface antibody (anti-HBs) shows protection, either from vaccination or from recovering after a past infection. Core antibody (anti-HBc) shows that a person has been infected at some point, past or present; vaccination alone does not produce it. A positive surface antigen that persists for six months or longer confirms chronic infection. After hepatitis B is found, further tests show how active it is and how the liver is coping. HBV DNA testing, often called the viral load, measures how much of the virus's genetic material is in the blood. ALT (alanine aminotransferase) is a liver enzyme that rises when liver cells are inflamed. Liver stiffness testing (elastography, a painless ultrasound-based scan) or occasionally a liver biopsy estimates scarring. Clinicians also check for hepatitis D, a related virus that infects only people who have hepatitis B and makes liver disease worse, in people at risk, and for HIV and hepatitis C.
A new infection in an adult usually needs only rest, fluids and monitoring while the body clears the virus. Antiviral treatment is reserved for the uncommon person whose acute illness becomes severe. Not everyone with chronic hepatitis B needs medicine right away. The decision rests on the viral load, the ALT level and the amount of liver scarring, rechecked over time because the infection moves through quieter and more active phases. Treatment is recommended when the virus is actively inflaming the liver or when there is significant scarring or cirrhosis. The main treatments are antiviral pills taken once a day: tenofovir, sold as tenofovir alafenamide (Vemlidy) or tenofovir disoproxil (Viread), and entecavir (Baraclude). They suppress the virus to very low or undetectable levels, calm liver inflammation and lower the risk of cirrhosis, liver failure and liver cancer. They rarely clear the virus completely, so treatment is usually long-term and often lifelong. Tenofovir alafenamide or entecavir is often chosen for people with kidney or bone concerns. Stopping these medicines can trigger a severe flare of hepatitis, so they should be stopped only with the prescriber's plan and close blood-test follow-up. Peginterferon is a weekly injection given for a set period, usually about a year. It offers a defined end point and a somewhat better chance of lasting control in some people, but it causes more side effects, such as flu-like symptoms, fatigue and mood changes, and is not suitable for people with advanced cirrhosis or some other conditions. In pregnancy, a person with a high viral load may take tenofovir during the third trimester to lower the chance of passing the virus to the baby. Every baby born to a mother with hepatitis B should receive hepatitis B immune globulin (HBIG, a dose of ready-made antibodies) and the first vaccine dose within 12 hours of birth, then complete the vaccine series. Breastfeeding is not prohibited. When hepatitis B leads to liver failure or liver cancer, a liver transplant may be an option.
Many people with chronic hepatitis B live full lives and never develop serious liver disease, but the infection needs lifelong attention. Even without treatment, regular blood tests, often every few months to once a year, track the viral load and ALT, because the infection can shift into a more active phase. For people on antivirals, follow-up checks that the virus stays suppressed and that the medicine is taken consistently. People with cirrhosis, and others at higher risk for liver cancer, such as those with a family history of liver cancer or with hepatitis D, and Asian and Black men over 40 and Asian women over 50 with chronic infection, are advised to have a liver ultrasound every six months. Treatment lowers but does not remove the risk of liver cancer, so this surveillance continues on medication. Found early, liver cancer is more often treatable. Daily life changes in a few practical ways. Alcohol adds to liver damage and is best avoided. Checking with a clinician before starting new medicines or supplements avoids extra strain on the liver. Not sharing razors or toothbrushes, covering cuts and using condoms protect others. Sex partners and household members should be tested and vaccinated if they are not already immune. Telling doctors and dentists about the infection helps keep care safe, and people with hepatitis B should not donate blood, organs or semen. The virus can also reawaken. In someone with chronic or even past hepatitis B, chemotherapy, rituximab and other medicines that suppress the immune system, steroids taken for more than a few weeks, or an organ or stem cell transplant can reactivate the virus and cause serious liver injury. Testing beforehand allows preventive antiviral treatment when it is needed.
Arrange a routine visit to be tested if you have never been screened as an adult, if you are pregnant, or if you have a partner or family member with hepatitis B. If you have hepatitis B, see a clinician experienced in liver disease to plan monitoring, and tell any doctor who plans chemotherapy, immune-suppressing treatment or a transplant so that you can be tested and protected beforehand. If you have not been vaccinated and may have been exposed to the virus, for example through a needlestick or sex with a partner who has hepatitis B, see a clinician right away. A vaccine dose, sometimes with HBIG, works best within 24 hours. Contact your care team if you notice yellowing of the skin or eyes, dark urine or pale stools, if symptoms of a new infection last more than two to three weeks, or if you have stopped or run out of your antiviral medicine. New confusion or drowsiness, vomiting blood, or black or bloody stools need emergency medical care for anyone with hepatitis B, especially during a new infection, after stopping an antiviral or with cirrhosis, as does belly swelling that appears or worsens quickly in someone with cirrhosis.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hepatitis B is like, what's helped you, or ask the community a question.